Ou-Yang Mei-Chen, Tsai Ming-Horng, Chu Shih-Ming, Chen Chih-Chen, Yang Peng-Hong, Huang Hsuan-Rong, Chang Ching-Min, Fu Ren-Huei, Hsu Jen-Fu
Division of Pediatric Neonatology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33382, Taiwan.
College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
Antibiotics (Basel). 2023 Jun 30;12(7):1131. doi: 10.3390/antibiotics12071131.
: We aimed to describe the clinical features of Gram-negative bacillary (GNB) meningitis in neonates and investigate the risk factors associated with final adverse outcomes of neonatal GNB meningitis. : From 2003 to 2020, all neonates (aged ≤ 90 days old) with bacterial meningitis who were hospitalized in four tertiary-level neonatal intensive care units (NICUs) of two medical centers in Taiwan were enrolled. Neonates with GNB meningitis were compared with those with Streptococcus agalactiae (group B streptococcus, GBS) meningitis. : During the study period, a total of 153 neonates with bacterial meningitis were identified and enrolled. GNB and GBS accounted for 40.5% ( = 62) and 35.3% ( = 54) of all neonatal bacterial meningitis, respectively. In neonates with GNB meningitis, the final mortality rate was 6.5% (4 neonates died); 48 (77.4%) had neurological complications, and 26 (44.8%) of 58 survivors had neurological sequelae at discharge. Although the final outcomes were comparable between neonates with GNB meningitis and those with GBS meningitis, neonates with GNB meningitis were more likely to have more severe clinical manifestations initially and have ventriculomegaly at follow-up. After multivariate logistic regression analysis, neonates with seizure at onset, early onset sepsis, and requirement of surgical intervention for neurological complications were independently associated with final adverse outcomes. : GNB meningitis was associated with a high risk of neurological complications and sequelae, although it did not significantly increase the final mortality rate. Close monitoring of the occurrence of neurological complications and advanced therapeutic strategies to optimize the outcomes are urgently needed in the future.
我们旨在描述新生儿革兰阴性杆菌(GNB)脑膜炎的临床特征,并调查与新生儿GNB脑膜炎最终不良结局相关的危险因素。2003年至2020年,纳入了台湾两个医疗中心的四个三级新生儿重症监护病房(NICU)中住院的所有细菌性脑膜炎新生儿(年龄≤90天)。将GNB脑膜炎新生儿与无乳链球菌(B组链球菌,GBS)脑膜炎新生儿进行比较。在研究期间,共确定并纳入了153例细菌性脑膜炎新生儿。GNB和GBS分别占所有新生儿细菌性脑膜炎的40.5%(n = 62)和35.3%(n = 54)。在GNB脑膜炎新生儿中,最终死亡率为6.5%(4例新生儿死亡);48例(77.4%)有神经并发症,58例幸存者中有26例(44.8%)在出院时有神经后遗症。尽管GNB脑膜炎新生儿和GBS脑膜炎新生儿的最终结局相当,但GNB脑膜炎新生儿最初更可能有更严重的临床表现,且在随访时有脑室扩大。多因素逻辑回归分析后,起病时惊厥、早发型败血症以及因神经并发症需要手术干预的新生儿与最终不良结局独立相关。GNB脑膜炎与神经并发症和后遗症的高风险相关,尽管它并未显著增加最终死亡率。未来迫切需要密切监测神经并发症的发生情况,并采取先进的治疗策略以优化结局。